Literature DB >> 2823852

Plasma amino acid patterns in hepatocellular carcinoma.

C Hirayama1, K Suyama, Y Horie, K Tanimoto, S Kato.   

Abstract

Plasma amino acid levels were determined in 23 patients in comparison with 16 normal subjects and 17 patients with liver cirrhosis. Patients with hepatocellular carcinoma had elevated levels of the aromatic amino acids and lowered levels of the branched-chain amino acids, as seen in liver cirrhosis; however, they had lowered levels of alanine and glutamine as compared with normal subjects and with liver cirrhosis patients. Following treatment with intraarterial chemotherapy and/or transcatheter arterial embolization, plasma levels of alanine and glutamine recovered. These results suggest that the consumption of alanine and glutamine increase in hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2823852     DOI: 10.1016/0885-4505(87)90071-5

Source DB:  PubMed          Journal:  Biochem Med Metab Biol        ISSN: 0885-4505


  5 in total

1.  Supramolecular Dye Aggregate Assembly Enables Ratiometric Detection and Discrimination of Lysine and Arginine in Aqueous Solution.

Authors:  Aafrin M Pettiwala; Prabhat K Singh
Journal:  ACS Omega       Date:  2017-12-08

2.  Plasma-free amino acid profiles in dogs with hepatocellular carcinoma.

Authors:  Rommaneeya Leela-Arporn; Hiroshi Ohta; Masahiro Tamura; Noriyuki Nagata; Kazuyoshi Sasaoka; Angkhana Dermlim; Khoirun Nisa; Tatsuyuki Osuga; Keitaro Morishita; Noboru Sasaki; Mitsuyoshi Takiguchi
Journal:  J Vet Intern Med       Date:  2019-05-08       Impact factor: 3.333

Review 3.  Metabolic alterations and vulnerabilities in hepatocellular carcinoma.

Authors:  Daniel G Tenen; Li Chai; Justin L Tan
Journal:  Gastroenterol Rep (Oxf)       Date:  2020-11-18

4.  Water-Soluble Single-Benzene Chromophores: Excited State Dynamics and Fluorescence Detection.

Authors:  Yingge Fan; Jin Ma; Huijing Liu; Taihong Liu
Journal:  Molecules       Date:  2022-08-27       Impact factor: 4.927

5.  Unveiling prognostics biomarkers of tyrosine metabolism reprogramming in liver cancer by cross-platform gene expression analyses.

Authors:  Tran N Nguyen; Ha Q Nguyen; Duc-Hau Le
Journal:  PLoS One       Date:  2020-06-15       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.